These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19204712)

  • 21. EBV-related lymphoproliferative disorders in immunocompetent patients.
    Oosterveld M; Lesterhuis WJ; MacKenzie M; van Krieken JH
    Leukemia; 2003 Dec; 17(12):2537-8. PubMed ID: 14523463
    [No Abstract]   [Full Text] [Related]  

  • 22. Epstein-Barr virus associated with a post-transplant lymphoproliferative disorder presenting as isolated gastrointestinal tract bleeding.
    Badham K; Mirchandani A; Arumainayagam N; West DR
    Endoscopy; 2007 Feb; 39 Suppl 1():E64-5. PubMed ID: 17323282
    [No Abstract]   [Full Text] [Related]  

  • 23. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
    Wu JF; Ho MC; Ni YH; Chen HL; Lu CY; Hsu HY; Lee PH; Chang MH
    Transplantation; 2009 Mar; 87(5):758-62. PubMed ID: 19295323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progressive transition of Epstein-Barr virus associated lymphoproliferative disease subtypes with the development of lung cancer.
    Taoka K; Nannya Y; Yamamoto G; Sakatani T; Ota S; Fukayama M; Takahashi T; Kurokawa M
    Am J Hematol; 2009 Sep; 84(9):600-3. PubMed ID: 19623671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Post-transplant lympho-proliferative disease associated to Epstein-Barr virus].
    Sánchez Fructuoso AI
    Nefrologia; 2005; 25(1):20-30. PubMed ID: 15789533
    [No Abstract]   [Full Text] [Related]  

  • 26. Gastrointestinal tract involvement of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after cord blood transplantation.
    Wakamatsu H; Akahane K; Kasai S; Watanabe A; Goi K
    Pediatr Int; 2022 Jan; 64(1):e15233. PubMed ID: 35831256
    [No Abstract]   [Full Text] [Related]  

  • 27. Epstein-Barr virus-associated B cell lymphoproliferative disease in a child with neonatal-onset multisystem inflammatory disease.
    Modica R; Emery H; Lam W; Hermiston M; Grenert J; Wirt M; von Scheven E
    Arthritis Rheum; 2006 Oct; 55(5):823-5. PubMed ID: 17013844
    [No Abstract]   [Full Text] [Related]  

  • 28. Iatrogenic lymphoproliferative disorder.
    Nader K; Behrens DS; Leon CA; Schwarting R; Ferber A
    Am J Hematol; 2014 Jul; 89(7):787-8. PubMed ID: 24729413
    [No Abstract]   [Full Text] [Related]  

  • 29. [Characteristics of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease].
    Kawa K
    Rinsho Ketsueki; 2008 Jun; 49(6):390-6. PubMed ID: 18646606
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
    Capello D; Rasi S; Oreste P; Veronese S; Cerri M; Ravelli E; Rossi D; Minola E; Colosimo A; Gambacorta M; Muti G; Morra E; Gaidano G
    J Pathol; 2009 Aug; 218(4):478-86. PubMed ID: 19391128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomics analysis in post-transplant lymphoproliferative disorders.
    Alsayed Y; Leleu X; Leontovich A; Oton AB; Melhem M; George D; Ghobrial IM
    Eur J Haematol; 2008 Oct; 81(4):298-303. PubMed ID: 18573174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epstein-Barr virus and hematological neoplasms].
    Kimura H
    Rinsho Ketsueki; 2012 Oct; 53(10):1874-82. PubMed ID: 23037764
    [No Abstract]   [Full Text] [Related]  

  • 33. Catastrophic gastrointestinal manifestations of post-transplant lymphoproliferative disorder.
    Hsu YC; Liao WC; Wang HP; Yao M; Lin JT
    Dig Liver Dis; 2009 Mar; 41(3):238-41. PubMed ID: 18083078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can a microarray implicate human genes in post-transplant lymphoproliferative disorders?
    Davies M; Rowe D
    Pediatr Transplant; 2009 Dec; 13(8):944-7. PubMed ID: 20470354
    [No Abstract]   [Full Text] [Related]  

  • 35. Posttransplantation lymphoproliferative disease with features of lymphomatoid granulomatosis in a lung transplant patient.
    Kwon EJ; Katz KA; Draft KS; Seykora JT; Rook AH; Wasik MA; Junkins-Hopkins JM
    J Am Acad Dermatol; 2006 Apr; 54(4):657-63. PubMed ID: 16546589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficiency of antiviral therapy plus IVIG in a case of primary EBV infection associated PTLD refractory to rituximab, chemotherapy, and antiviral therapy alone.
    Trappe R; Riess H; Anagnostopoulos I; Neuhaus R; Gärtner BC; Pohl H; Müller HP; Jonas S; Papp-Vary M; Oertel S
    Ann Hematol; 2009 Feb; 88(2):167-72. PubMed ID: 18636261
    [No Abstract]   [Full Text] [Related]  

  • 37. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
    Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-cell enrichment and infusion in CD4+/CD8+ T-cell depleted products for donor innate immune lymphocyte infusion: is risk of EBV-associated lymphocyte post transplantation lymphoproliferative disease a concern?
    Lamb LS; Sande J
    Bone Marrow Transplant; 2008 Jun; 41(11):995-6. PubMed ID: 18278072
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment for Epstein-Barr virus-associated PTLD.
    Gross TG
    Herpes; 2009 Jan; 15(3):64-7. PubMed ID: 19306606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus-associated, CD20- polyclonal lymphoproliferative disorder after matched unrelated donor marrow transplantation.
    Anderlini P; Valbuena JR; Champlin RE; Bueso-Ramos CE
    Bone Marrow Transplant; 2004 Nov; 34(10):919-21. PubMed ID: 15361906
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.